Home / Healthcare / Positive P

Positive Patient Identification (PPID) Market By Component (Scanning Devices, Software And Services), By Deployment Model (Web/Client Based, Cloud Based) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

Patient misidentification is one of the most serious issues faced by healthcare organizations worldwide. It occurs in several ways, with the root cause being the manual handling of the identification process. Some of the major instances of patient misidentification include providing false information intentionally, a change in the patient's name, an improper oral registration process, and others.

According to the American Health Information Management Association (AHIMA), over 40% of duplicate medical records are due to inconsistent records of the patients' first and last names. In the U.S., preventable medical errors cause more than 400,000 patient deaths every year. Typically, the average cost per misidentified record exceeds $1,000, resulting in significant financial loss throughout the year. This makes effective and reliable patient identification highly essential in healthcare organizations.

Positive patient identification refers to a system of hardware and software components used to identify a patient's identity. The hardware comprises scanning devices used for reading barcodes, RFID tags, and also biometrics. The scanned information is processed using integrated software and checked with the central information system of the organization.

With the rising trend of reducing the working hours of healthcare team members, the number of personnel caring for each patient increases. This makes miscommunication even more likely, eventually leading to patient misidentification. Subsequently, there can be a strong need for an automated patient identification solution that can reduce the number of identity thefts and misidentifications effectively.

1.1 Report Description

1.1.1 Purpose of the Report

The purpose of this strategic research study titled "Global Positive Patient Identification (PPID) Market: Growth, Future Prospects, and Competitive Analysis, 2016–2023" is to offer industry investors, company executives, and other industry participants with in-depth insights to enable them to make informed strategic decisions related to the opportunities in the global positive patient identification industry.

1.1.2 Target Audience

  • Industry Investors
  • PPID Scanning Equipment Manufacturers
  • PPID software developers
  • Cloud service providers
  • Government and Federal Agencies
  • Other End-users

On the basis of components, the global positive patient identification market is categorized into the following categories:

  • Scanning Equipment
  • Software & Services

Based on the components, the market for positive patient identification solutions is classified into scanning devices, software, and services. The overall market for positive patient identification is divided into components such as scanning equipment, software, and services. As of 2015, the overall positive patient identification market worldwide was dominated by the software and services segment.

The segment comprises initial software installation, maintenance, and upgrading. Due to the periodic maintenance and upgrading required, the segment is projected to retain its dominant position in the market throughout the forecast period.

The increasing deployment of cloud-based patient identification systems in small and midsized healthcare facilities around the world is also contributing to segment growth. Subsequently, the software and services segment is projected to register the highest growth rate during the forecast period.

On the basis of the deployment model, the positive patient identification market is classified into the following categories:

  • Cloud-based PPID
  • Web-based PPID

On the basis of deployment models, the global positive patient identification market is segmented into web- and client-based deployment models and cloud-based solutions. As of 2015, the overall positive patient identification market was led by the web-based deployment segment.

Client-based positive patient identification solutions are expensive due to the high initial investment required to set up the required IT infrastructure.

Nevertheless, with the rising penetration of cloud services across the globe, the cloud-based segment is projected to register the highest growth rate during the forecast period. These solutions are relatively inexpensive as they require little or no initial investment in IT infrastructure. As a result, the segment attracts small and mid-sized healthcare service providers for PPID deployment.

On the basis of geography, the global market for positive patient identification is segmented into the following regions and countries:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • Australasia
  • Rest of Asia Pacific
  • Rest of the World (RoW)
  • Middle East and Africa (MEA)
  • Latin America

As of 2015, the North American region dominated the global market for positive patient identification, accounting for more than half of the total market revenue. The region is home to a huge healthcare industry with strong spending on IT and automation systems. Due to the strong anticipated growth in the healthcare IT sector here, the region is estimated to remain dominant throughout the forecast period.

Europe follows North America in the overall positive patient identification market. Asia Pacific is expected to register the highest growth in the market during the forecast period. The growth is primarily expected from countries with strong healthcare IT sectors, such as Japan, Australia, China, and South Korea. In addition, Southeast Asia and India are expected to emerge as highly promising markets due to the rapidly growing healthcare industries here.

Frequently Asked Question:

The market for Positive Patient Identification Market is expected to reach USD$ XX in 2023.

The Positive Patient Identification Market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2016 -2023.

The base year of this report is 2015.

Imprivata, Inc., RightPatient, Inc., General Data Company, Inc., GBS Corporation. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Dec 2016
Category:  Healthcare
Report ID:   58280
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support